{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T19:26:29Z","timestamp":1793820389973,"version":"4.6.1"},"reference-count":114,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.survophthal.2021.06.002","type":"journal-article","created":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T06:25:06Z","timestamp":1624429506000},"page":"427-439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Use of erythropoietin in ophthalmology: a review"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4457-8077","authenticated-orcid":false,"given":"Sepehr","family":"Feizi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadhasan","family":"Alemzadeh-Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farid","family":"Karimian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Esfandiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.survophthal.2021.06.002_bib0001","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s10792-017-0553-z","article-title":"Intravitreal erythropoietin injection in late-stage optic neuropathy: a safety study on human","volume":"38","author":"Acar","year":"2018","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0002","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/IJG.0b013e31829e54ec","article-title":"The effect of systemic erythropoietin treatment on retinal nerve fiber layer parameters in patients with chronic renal failure undergoing peritoneal dialysis","volume":"24","author":"Aktas","year":"2015","journal-title":"J Glaucoma"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0003","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.yexcr.2018.12.013","article-title":"Erythropoietin in tumor angiogenesis","volume":"374","author":"Annese","year":"2019","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0004","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1681\/ASN.2011111078","article-title":"Mechanisms of anemia in CKD","volume":"23","author":"Babitt","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0006","first-page":"151","article-title":"Erythropoietin for acute multiple sclerosis in patients with optic neuritis as a first demyelination event","volume":"17","author":"Borhani-Haghighi","year":"2012","journal-title":"Neurosciences (Riyadh)"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0008","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jaapos.2005.09.005","article-title":"Association between higher cumulative doses of recombinant erythropoietin and risk for retinopathy of prematurity","volume":"10","author":"Brown","year":"2006","journal-title":"J AAPOS"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0009","first-page":"307","article-title":"The erythropoietin receptor is not required for the development, function, and aging of rods and cells in the retinal periphery","volume":"20","author":"Caprara","year":"2014","journal-title":"Mol Vis"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0010","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.3109\/02713683.2012.713156","article-title":"Intravitreal injection of soluble erythropoietin receptor exacerbates photoreceptor cell apoptosis in a rat model of retinal detachment","volume":"37","author":"Chen","year":"2012","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0011","first-page":"526","article-title":"Erythropoietin deficiency decreases vascular stability in mice","volume":"118","author":"Chen","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0012","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1167\/iovs.07-1641","article-title":"Interleukin-6 as a photoreceptor neuroprotectant in an experimental model of retinal detachment","volume":"49","author":"Chong","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0013","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1002\/jnr.22046","article-title":"Neuroprotective role of erythropoietin by antiapoptosis in the retina","volume":"87","author":"Chung","year":"2009","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0014","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1093\/hmg\/ddr115","article-title":"Non-erythropoietic erythropoietin derivatives protect from light-induced and genetic photoreceptor degeneration","volume":"20","author":"Colella","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0015","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/IJG.0b013e31804a5eb3","article-title":"Aqueous humor erythropoietin levels in patients with primary open-angle glaucoma","volume":"16","author":"Cumurcu","year":"2007","journal-title":"J Glaucoma"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0016","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.2741\/1982","article-title":"WNT\/Frizzled signaling in eye development and disease","volume":"11","author":"de Iongh","year":"2006","journal-title":"Front Biosci"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0017","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/brain\/awh365","article-title":"Combined therapy with methylprednisolone and erythropoietin in a model of multiple sclerosis","volume":"128","author":"Diem","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0018","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/35088074","article-title":"Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades","volume":"412","author":"Digicaylioglu","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0019","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s10792-010-9391-y","article-title":"Aqueous humor and serum erythropoietin levels in patients with pseudoexfoliation syndrome and pseudoexfoliative glaucoma","volume":"30","author":"Do\u011fu","year":"2010","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0020","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.survophthal.2012.11.002","article-title":"The spectrum of postoperative scleral necrosis","volume":"58","author":"Doshi","year":"2013","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0021","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/sj.mp.4001907","article-title":"Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin","volume":"12","author":"Ehrenreich","year":"2007","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0022","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1007\/s00417-014-2691-6","article-title":"A pilot study of the effect of intravenous erythropoetin on improvement of visual function in patients with recent indirect traumatic optic neuropathy","volume":"252","author":"Entezari","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0023","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1007\/s00417-019-04383-2","article-title":"Combination of intravitreal bevacizumab and erythropoietin versus intravitreal bevacizumab alone for refractory diabetic macular edema: a randomized double-blind clinical trial","volume":"257","author":"Entezari","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0024","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-3387","article-title":"Interventions to prevent retinopathy of prematurity: a meta-analysis","volume":"137","author":"Fang","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0025","article-title":"Topical erythropoietin as a novel treatment for necrotizing scleritis after pterygium surgery: a pilot study","volume":"Nov 4","author":"Feizi","year":"2020","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2019.107898","article-title":"Effects of topical erythropoietin on healing experimentally-induced avascular scleral damage in a rabbit model","volume":"190","author":"Feizi","year":"2020","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0027","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/sj.eye.6702924","article-title":"Incidence and risk factors for retinopathy of prematurity in very low and in extremely low birth weight infants in a unit-based approach in southern Brazil","volume":"23","author":"Fortes Filho","year":"2009","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0028","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1046\/j.1523-1755.64.s87.9.x","article-title":"Treating azotemia-induced anemia with erythropoietin improves diabetic eye disease","volume":"64","author":"Friedman","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0029","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10571-007-9155-z","article-title":"Up-regulated endogenous erythropoietin\/erythropoietin receptor system and exogenous erythropoietin rescue retinal ganglion cells after chronic ocular hypertension","volume":"28","author":"Fu","year":"2008","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0030","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/eye.2008.230","article-title":"Vitreous levels of erythropoietin in patients with macular oedema secondary to retinal vein occlusions: a comparative study with diabetic macular oedema","volume":"23","author":"Garc\u00eda-Arum\u00ed","year":"2009","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0031","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s40478-014-0084-z","article-title":"Angiogenesis in multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"2","author":"Girolamo","year":"2014","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0032","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3109\/02713683.2011.582661","article-title":"Effects of single intravitreal rhEPO injection on light-induced retinal injury in rats","volume":"36","author":"Gong","year":"2011","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0034","doi-asserted-by":"crossref","first-page":"5651","DOI":"10.1523\/JNEUROSCI.1288-04.2004","article-title":"Constitutive overexpression of human erythropoietin protects the mouse retina against induced but not inherited retinal degeneration","volume":"24","author":"Grimm","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0035","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.2174\/15665240113139990071","article-title":"Subretinal transplantation of rat MSCs and erythropoietin gene modified rat MSCs for protecting and rescuing degenerative retina in rats","volume":"13","author":"Guan","year":"2013","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0036","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.3892\/mmr.2014.2859","article-title":"HIF-1 signaling pathway involving iNOS, COX-2 and caspase-9 mediates the neuroprotection provided by erythropoietin in the retina of chronic ocular hypertension rats","volume":"11","author":"Gui","year":"2015","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0037","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s10741-008-9086-x","article-title":"Iron and anemia in human biology: a review of mechanisms","volume":"13","author":"Handelman","year":"2008","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0038","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s12020-011-9579-6","article-title":"Erythropoietin produced by the retina: its role in physiology and diabetic retinopathy","volume":"41","author":"Hern\u00e1ndez","year":"2012","journal-title":"Endocrine"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0039","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1600-0609.2007.00818.x","article-title":"Erythropoietin after a century of research: younger than ever","volume":"78","author":"Jelkmann","year":"2007","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0040","doi-asserted-by":"crossref","first-page":"10659","DOI":"10.1073\/pnas.152321399","article-title":"Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury","volume":"99","author":"Junk","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0041","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1907423","article-title":"A randomized trial of erythropoietin for neuroprotection in preterm infants","volume":"382","author":"Juul","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0042","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/eye.2014.95","article-title":"The effect of erythropoietin on the severity of retinopathy of prematurity","volume":"28","author":"- Kandasamy","year":"2014","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0043","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s00417-010-1534-3","article-title":"Erythropoietin: a novel treatment for traumatic optic neuropathy-a pilot study","volume":"249","author":"Kashkouli","year":"2011","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0044","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00417-017-3816-5","article-title":"Traumatic optic neuropathy treatment trial (TONTT): open label, phase 3, multicenter, semi-experimental trial","volume":"256","author":"Kashkouli","year":"2018","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0045","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/sj.ki.5002482","article-title":"Antioxidative effects of erythropoietin","volume":"107","author":"Katavetin","year":"2007","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0046","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.2337\/diacare.28.9.2252","article-title":"Erythropoietin is highly elevated in vitreous fluid of patients with proliferative diabetic retinopathy","volume":"28","author":"Katsura","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0047","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1096\/fj.04-2493fje","article-title":"Erythropoietin protects from axotomy-induced degeneration of retinal ganglion cells by activating ERK-1\/-2","volume":"19","author":"Kilic","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0048","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.expneurol.2007.01.017","article-title":"Erythropoietin is both neuroprotective and neuroregenerative following optic nerve transection","volume":"205","author":"King","year":"2007","journal-title":"Exp Neurol"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0049","doi-asserted-by":"crossref","first-page":"7485","DOI":"10.1167\/iovs.11-7781","article-title":"The influence of alloxan-induced diabetes on M\u00fcller cell contraction-promoting activities in vitreous","volume":"52","author":"King","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0050","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2215\/CJN.03220807","article-title":"Toxic alcohol ingestions: clinical features, diagnosis, and management","volume":"3","author":"Kraut","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0051","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.mcn.2005.04.009","article-title":"Erythropoietin promotes regeneration of adult CNS neurons via Jak2\/Stat3 and PI3K\/AKT pathway activation","volume":"29","author":"Kretz","year":"2005","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0052","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1136\/bjo.2008.156794","article-title":"Feasibility of intravitreal erythropoietin injections in humans","volume":"93","author":"Lagr\u00e8ze","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0053","doi-asserted-by":"crossref","first-page":"e609","DOI":"10.1038\/cddis.2013.126","article-title":"Interleukin-6 contributes to CNS axon regeneration upon inflammatory stimulation","volume":"4","author":"Leibinger","year":"2013","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0054","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.bone.2006.03.017","article-title":"Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia","volume":"39","author":"Li","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0055","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3928\/15428877-20091230-03","article-title":"Effects of intravitreal erythropoietin therapy for patients with chronic and progressive diabetic macular edema","volume":"41","author":"Li","year":"2010","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0056","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118273","article-title":"Erythropoietin maintains VE-cadherin expression and barrier function in experimental diabetic retinopathy via inhibiting VEGF\/VEGFR2\/Src signaling pathway","volume":"259","author":"Liu","year":"2020","journal-title":"Life Sci"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0057","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/j.lfs.2005.09.053","article-title":"Mechanism of the cardioprotection of rhEPO pretreatment on suppressing the inflammatory response in ischemia-reperfusion","volume":"78","author":"Liu","year":"2006","journal-title":"Life Sci"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0058","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000351627","article-title":"Effect of erythropoietin on healing of corneal epithelial defects in rabbits","volume":"50","author":"Livny","year":"2013","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0059","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/eci.12357","article-title":"High-dose erythropoietin for tissue protection","volume":"44","author":"Lund","year":"2014","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0060","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00417-016-3290-5","article-title":"Epo inhibits the fibrosis and migration of M\u00fcller glial cells induced by TGF-\u03b2 and high glucose","volume":"254","author":"Luo","year":"2016","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"suppl 2","key":"10.1016\/j.survophthal.2021.06.002_bib0061","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/S0378-3782(14)50009-6","article-title":"Use of erythropoietin is associated with threshold retinopathy of prematurity (ROP) in preterm ELBW neonates: a retrospective, cohort study from two large tertiary NICUs in Italy","volume":"90","author":"Manzoni","year":"2014","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0062","first-page":"1","article-title":"Preterm Epo Neuroprotection (PENUT) Trial Consortium. High-dose erythropoietin in extremely low gestational age neonates does not alter risk of retinopathy of prematurity","author":"Mayock","year":"2020","journal-title":"Neonatology"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0063","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.2337\/db11-0026","article-title":"Intervention with an erythropoietin-derived peptide protects against neuroglial and vascular degeneration during diabetic retinopathy","volume":"60","author":"McVicar","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0064","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1136\/bjo.2010.191627","article-title":"Intravitreal erythropoietin injection for the treatment of non-arteritic anterior ischaemic optic neuropathy","volume":"95","author":"Modarres","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0065","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1442-9071.2010.02318.x","article-title":"Erythropoietin and soluble CD44 levels in patients with primary open-angle glaucoma","volume":"38","author":"Mokbel","year":"2010","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0066","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/emboj\/cdg117","article-title":"HLF\/HIF-2alpha is a key factor in retinopathy of prematurity in association with erythropoietin","volume":"22","author":"Morita","year":"2003","journal-title":"EMBO J"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0067","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/bjo.72.10.778","article-title":"Optic nerve involvement in a case of methanol poisoning","volume":"72","author":"Naeser","year":"1988","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0068","first-page":"1991","article-title":"Erythropoietin levels in aqueous humor of patients with glaucoma","volume":"18","author":"Nassiri","year":"2012","journal-title":"Mol Vis"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0069","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1007\/s00417-020-04781-x","article-title":"The effect of systemic erythropoietin and oral prednisolone on recent-onset non-arteritic anterior ischemic optic neuropathy: a randomized clinical trial","volume":"258","author":"Nikkhah","year":"2020","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0070","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004863.pub2","article-title":"Early erythropoietin for preventing red blood cell transfusion in preterm and\/or low birth weight infants","author":"Ohlsson","year":"2006","journal-title":"Cochrane Database of Sys Rev"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0071","article-title":"Early erythropoiesis-stimulating agents in preterm or low birth weight infants","volume":"2","author":"Ohlsson","year":"2020","journal-title":"Cochrane Database of Syst Rev"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0072","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/WNO.0000000000000614","article-title":"Erythropoietin in treatment of methanol optic neuropathy","volume":"38","author":"Pakdel","year":"2018","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0073","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1080\/02713683.2016.1270328","article-title":"The effect of combined systemic erythropoietin and steroid on non-arteritic anterior ischemic optic neuropathy: a prospective study","volume":"42","author":"Pakravan","year":"2017","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0074","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1080\/00952990.2016.1198800","article-title":"Erythropoietin as an adjunctive treatment for methanol-induced toxic optic neuropathy","volume":"42","author":"Pakravan","year":"2016","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0075","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/WNO.0b013e318262a7c2","article-title":"Erythropoietin treatment for methanol optic neuropathy","volume":"32","author":"Pakravan","year":"2012","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0076","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1203\/PDR.0b013e318165b8d1","article-title":"Elevated erythropoietin mRNA and protein concentrations in the developing human eye","volume":"63","author":"Patel","year":"2008","journal-title":"Pediatr Res"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0077","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/2750632","article-title":"Visual-evoked-response-supported outcome of intravitreal erythropoietin in management of indirect traumatic optic neuropathy","volume":"2018","author":"Rashad","year":"2018","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0078","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000488970","article-title":"Functional and structural effects of erythropoietin subconjunctival administration in glaucomatous animals","volume":"3","author":"Resende","year":"2018","journal-title":"Biomed Hub"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0079","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1007\/s00417-013-2367-7","article-title":"Alternative route for erythropoietin ocular administration","volume":"251","author":"Resende","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0080","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.ymthe.2004.07.027","article-title":"Systemic but not intraocular Epo gene transfer protects the retina from light-and genetic-induced degeneration","volume":"10","author":"Rex","year":"2004","journal-title":"Mol Ther"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0081","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157411","article-title":"Erythropoietin slows photoreceptor cell death in a mouse model of autosomal dominant retinitis pigmentosa","volume":"11","author":"Rex","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0082","doi-asserted-by":"crossref","first-page":"299","DOI":"10.18502\/jovr.v14i3.4786","article-title":"Visual outcomes of adding erythropoietin to methylprednisolone for Treatment of retrobulbar optic neuritis","volume":"14","author":"Sanjari","year":"2019","journal-title":"J Ophthalmic Vis Res"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0083","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.ophtha.2008.12.023","article-title":"Vitreous levels of erythropoietin and vascular endothelial growth factor in eyes with retinopathy of prematurity","volume":"116","author":"Sato","year":"2009","journal-title":"Ophthalmology"},{"issue":"Suppl 2","key":"10.1016\/j.survophthal.2021.06.002_bib0084","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.1038\/sj.cdd.4401504","article-title":"Neuroprotective effects and intracellular signaling pathways of erythropoietin in a rat model of multiple sclerosis","volume":"11","author":"S\u00e4ttler","year":"2004","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0085","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1592\/phco.28.11.1335","article-title":"Use of recombinant human erythropoietin and risk of severe retinopathy in extremely low-birth-weight infants","volume":"28","author":"Schneider","year":"2008","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0087","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s00417-014-2925-7","article-title":"A double-blind, placebo-controlled trial of adding erythropoietin to intravenous methylprednisolone for the treatment of unilateral acute optic neuritis of unknown or demyelinative origin","volume":"253","author":"Shayegannejad","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0088","article-title":"Systemic administration of erythropoietin inhibits retinopathy in RCS rats","volume":"9","author":"Shen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0089","first-page":"501","article-title":"Aqueous levels of erythropoietin in acute retinal vein occlusion with macular edema","volume":"7","author":"Shin","year":"2014","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0090","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1097\/IAE.0b013e3181d37539","article-title":"Vitreal levels of erythropoietin are increased in patients with retinal vein occlusion and correlate with vitreal VEGF and the extent of macular edema","volume":"30","author":"Stahl","year":"2010","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0091","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1089\/hum.2011.052","article-title":"Systemic adeno-associated virus-mediated gene therapy preserves retinal ganglion cells and visual function in DBA\/2J glaucomatous mice","volume":"22","author":"Sullivan","year":"2011","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0092","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.exer.2012.01.006","article-title":"Dose-dependent treatment of optic nerve crush by exogenous systemic mutant erythropoietin","volume":"96","author":"Sullivan","year":"2012","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0093","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s11064-010-0272-6","article-title":"Systemic gene delivery protects the photoreceptors in the retinal degeneration slow mouse","volume":"36","author":"Sullivan","year":"2011","journal-title":"Neurochem Res"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0094","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jaapos.2007.08.009","article-title":"Human recombinant erythropoietin and the incidence of retinopathy of prematurity: a multiple regression model","volume":"12","author":"Suk","year":"2008","journal-title":"J AAPOS"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0095","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1186\/s12967-020-02562-y","article-title":"Effect of early prophylactic low-dose recombinant human erythropoietin on retinopathy of prematurity in very preterm infants","volume":"18","author":"Sun","year":"2020","journal-title":"J Transl Med"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0096","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/ana.23573","article-title":"A randomized, double-blind, phase 2 study of erythropoietin in optic neuritis","volume":"72","author":"S\u00fchs","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0097","doi-asserted-by":"crossref","first-page":"14139","DOI":"10.1074\/jbc.275.19.14139","article-title":"Hypoxic induction of prolyl 4-hydroxylase alpha (I) in cultured cells","volume":"275","author":"Takahashi","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0098","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1080\/10717544.2018.1556361","article-title":"Intranasal administration of erythropoietin rescues the photoreceptors in degenerative retina: a noninvasive method to deliver drugs to the eye","volume":"26","author":"Tao","year":"2019","journal-title":"Drug Deliv"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0099","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/fcp.12494","article-title":"Adeno-associated virus (AAV)-mediated neuroprotective effects on the degenerative retina: the therapeutic potential of erythropoietin","volume":"34","author":"Tao","year":"2020","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0100","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/IJG.0b013e318156a556","article-title":"Erythropoietin: a candidate neuroprotective agent in the treatment of glaucoma","volume":"16","author":"Tsai","year":"2007","journal-title":"J Glaucoma"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0101","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1080\/02713680500320729","article-title":"Intravitreal administration of erythropoietin and preservation of retinal ganglion cells in an experimental rat model of glaucoma","volume":"30","author":"Tsai","year":"2005","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0102","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1159\/000330085","article-title":"Long-term treatment with suberythropoietic Epo is vaso- and neuroprotective in experimental diabetic retinopathy","volume":"27","author":"Wang","year":"2011","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0103","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s00125-010-1727-7","article-title":"Low-dose erythropoietin inhibits oxidative stress and early vascular changes in the experimental diabetic retina","volume":"53","author":"Wang","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0104","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.freeradbiomed.2008.11.027","article-title":"Erythropoietin protects retinal pigment epithelial cells from oxidative damage","volume":"46","author":"Wang","year":"2009","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0105","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000228592","article-title":"Elevated erythropoietin in vitreous of patients with rhegmatogenous retinal detachment and proliferative vitreoretinopathy","volume":"42","author":"Wang","year":"2009","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0106","doi-asserted-by":"crossref","first-page":"680","DOI":"10.3109\/02713681003778780","article-title":"Erythropoietin is increased in aqueous humor of glaucomatous eyes","volume":"35","author":"Wang","year":"2010","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0107","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1056\/NEJMoa041773","article-title":"Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy","volume":"353","author":"Watanabe","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0108","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00125-020-05299-x","article-title":"Erythropoietin protects the inner blood\u2013retinal barrier by inhibiting microglia phagocytosis via Src\/Akt\/cofilin signalling in experimental diabetic retinopathy","volume":"64","author":"Xie","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0109","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3109\/02713683.2011.647225","article-title":"Effects of supplemental erythropoietin on its receptor expression and signal transduction pathways in rat model of retinal detachment","volume":"37","author":"Xie","year":"2012","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0110","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/eye.2011.254","article-title":"Safety and efficacy of intravitreal injection of recombinant erythropoietin for protection of photoreceptor cells in a rat model of retinal detachment","volume":"26","author":"Xie","year":"2012","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0111","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/02713680701531074","article-title":"Expression pattern of erythropoietin and erythropoietin receptor in experimental model of retinal detachment","volume":"32","author":"Xie","year":"2007","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0112","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.brainres.2005.05.037","article-title":"Neuroprotective effects of erythropoietin on glutamate and nitric oxide toxicity in primary cultured retinal ganglion cells","volume":"1050","author":"Yamasaki","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0113","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/ceo.13619","article-title":"Erythropoietin protects outer blood-retinal barrier in experimental diabetic retinopathy by up-regulating ZO-1 and occludin","volume":"47","author":"Zhang","year":"2019","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0114","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1167\/iovs.07-0721","article-title":"Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes","volume":"49","author":"Zhang","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0115","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1111\/j.1745-7254.2008.00885.x","article-title":"Pharmacokinetic and toxicity study of intravitreal erythropoietin in rabbits","volume":"29","author":"Zhang","year":"2008","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0117","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1167\/iovs.06-0757","article-title":"Erythropoietin promotes survival of retinal ganglion cells in DBA\/2J glaucoma mice","volume":"48","author":"Zhong","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0118","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1089\/jop.2008.0021","article-title":"Erythropoietin with retrobulbar administration protects retinal ganglion cells from acute elevated intraocular pressure in rats","volume":"24","author":"Zhong","year":"2008","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.survophthal.2021.06.002_bib0119","doi-asserted-by":"crossref","first-page":"3874","DOI":"10.1167\/iovs.12-11507","article-title":"Levels of erythropoietin and vascular endothelial growth factor in surgery-required advanced neovascular glaucoma eyes before and after intravitreal injection of bevacizumab","volume":"54","author":"Zhou","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625721001399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625721001399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:53:07Z","timestamp":1758541987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625721001399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":114,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0039625721001399"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2021.06.002","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of erythropoietin in ophthalmology: a review","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2021.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}